mounjaro eli lilly - Search News

Order byBest matchMost fresh

Eli Lilly hikes Mounjaro prices in the UK

Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US

Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump administration.

· 1d · on MSN

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs

· 1d · on MSN

Lilly to hike UK price of Mounjaro weight-loss drug by 170%

· 19h

Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli Lilly

The two biggest weight-loss drugmakers have lost $252bn in value this year, as investor enthusiasm for obesity treatments wanes and Donald Trump’s tariff and price-cut threats weigh on the pharmaceut...

· 1d

Your ultimate guide to beat the Mounjaro price hike – from switching jabs to getting them FREE on the NHS

· 1d

Cost of Mounjaro weight-loss drug to go up by 170% in the UK within weeks

· 1d

Cost of weight-loss drug Mounjaro could rise significantly

Estimates suggest nine in 10 pay for these drugs privately, buying from online services and high street pharmacies.

i · 1h

'I'm bulk buying Mounjaro ahead of price hike — it's changed my life'

· 1d

Mounjaro rivals Wegovy and Retatrutide explained as price hiked for millions of users

16don MSN

Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type 2 diabetes.

15h

Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom. The moves underscore growing competition with Danish rival Novo Nordisk A/S (NYSE:NVO) in the lucrative obesity drug market.

2don MSN

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry

Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India, stepping up competition with Novo Nordisk .

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading to millions in improper Medicaid claims.

Mounjaro KwikPen by Lilly debuts in India at ₹14,000 for diabetes, obesity

Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets diabetes and obesity, competing with Wegovy

New programme with Mounjaro maker to tackle obesity in pharmacies

The Government and pharmaceutical giant Eli Lilly, the creator of weight loss drug Mounjaro, are teaming up to explore and trial innovative solutions to the UK's obesity crisis, inviting NHS organisations to put forward fresh proposals.